Literature DB >> 6618676

Studies on lamoxactam penetration into the aqueous humor of the human eye.

K F Manthey, U Ullmann.   

Abstract

Eighteen patients scheduled for surgical lens removal were assigned to six groups of three patients each. These patients received 25 mg/kg lamoxactam i. v. 30 to 180 min prior to surgery. In the course of the operation, aqueous humor was obtained and a serum sample taken to determine the antibiotic concentration. The mean peak serum level was 154.5 mg/l after 30 min; it was still 46.4 mg/l after 3 h. The lamoxactam concentrations in the aqueous humor increased slowly. Peak levels after 2 h were 4.2 mg/l. The ratio of aqueous humor level: serum level after 1 h was 4.7%, after 1.5 h 5.3% and after 2 h 6.9%. The ratio then remained constant up to the third hour. Aside from some gram-positive bacterial species and Pseudomonas species, all relevant microorganisms which cause eye infections are included in lamoxactam's spectrum of susceptibility.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6618676     DOI: 10.1007/bf01641200

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  5 in total

1.  Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. Implications for therapy of gram-negative bacillary meningitis.

Authors:  S H Landesman; M L Corrado; C C Cherubin; M Gombert; D Cleri
Journal:  Am J Med       Date:  1980-07       Impact factor: 4.965

2.  The pharmacokinetics of LY127935, a broad spectrum oxa-beta-lactam.

Authors:  R Wise; S Baker; N Wright; R Livingston
Journal:  J Antimicrob Chemother       Date:  1980-05       Impact factor: 5.790

3.  In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.

Authors:  C N Baker; C Thornsberry; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

4.  Penetration of intravenous moxalactam into human aqueous humor.

Authors:  M M Uwaydah; N Jabbour; S Fahd; M Jaafar; B M Faris
Journal:  Arch Ophthalmol       Date:  1982-02

5.  Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.

Authors:  R N Jones; P C Fuchs; H M Sommers; T L Gavan; A L Barry; E H Gerlach
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.